CRISPR Therapeutics AG (CRSP) short interest & options flow
NASDAQCRSP has cleared its November 3 earnings hurdle, and the market's immediate verdict was unenthusiastic: the stock fell 2.8% on the week to $49.99, even as most gene-editing peers held flat or gained. The short position has stabilised rather than retreated further after the print. Short interest now sits at 16.2% of free float, down just 3% on the week and roughly 22% below…
CRSP short interest climbs to 25.88% of float, up 20.8% in one week as gene-editing sentiment weakens.
- Market cap
- $5.02B
- Next earnings
- 11 Feb 2027
Key data as of 5 Nov 2026
CRSP news and analysis
RSSNo long-form analysis yet for CRSP. Pulse alerts and the live data picture are available on ORTEX.
Open CRSP on ORTEX →Want the live picture for CRSP?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRSP — free to start on ORTEX.
Sign up for free →Open CRSP on ORTEX